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ABSTRACT
Endochondral ossification is a carefully orchestrated process mediated by promoters and inhibitors of mineralization. Phosphatases are
implicated, but their identities and functions remain unclear. Alkaline phosphatase (TNAP) plays a crucial role promoting mineralization
of the extracellular matrix by restricting the concentration of the calcification inhibitor inorganic pyrophosphate (PPi). Mutations in the
TNAP gene cause hypophosphatasia, a heritable form of rickets and osteomalacia. Here we show that PHOSPHO1, a phosphatase with
specificity for phosphoethanolamine and phosphocholine, plays a functional role in the initiation of calcification and that ablation of
PHOSPHO1 and TNAP function prevents skeletal mineralization. Phospho1/ mice display growth plate abnormalities, spontaneous
fractures, bowed long bones, osteomalacia, and scoliosis in early life. Primary cultures of Phospho1/ tibial growth plate chondrocytes
and chondrocyte-derived matrix vesicles (MVs) show reduced mineralizing ability, and plasma samples from Phospho1/ mice show
reduced levels of TNAP and elevated plasma PPi concentrations. However, transgenic overexpression of TNAP does not correct the bone
phenotype in Phospho1/ mice despite normalization of their plasma PPi levels. In contrast, double ablation of PHOSPHO1 and TNAP
function leads to the complete absence of skeletal mineralization and perinatal lethality. We conclude that PHOSPHO1 has a
nonredundant functional role during endochondral ossification, and based on these data and a review of the current literature, we
propose an inclusive model of skeletal calcification that involves intravesicular PHOSPHO1 function and Pi influx into MVs in the initiation
of mineralization and the functions of TNAP, nucleotide pyrophosphatase phosphodiesterase-1, and collagen in the extravesicular
progression of mineralization.  2011 American Society for Bone and Mineral Research.
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Introduction
In the process of endochondral bone formation, chondrocytesand osteoblasts mineralize their extracellular matrix (ECM) at
least in part by promoting deposition of crystalline hydro-
xyapatite (HA) in the sheltered interior of membrane-bounded
matrix vesicles (MVs)—submicroscopic extracellular mem-
brane–invested bodies enriched in phosphatases.(1,2) Early
mineralization takes place inside these organelles, which serve
as a site for Ca2þ and Pi accumulation to initiate the deposition of
HA crystals.(3,4) In a second step, MV membranes subsequently
rupture and/or break down, exposing preformed HA to the
extracellular fluid and allowing for propagation of HA deposition
within the ECM. Inorganic pyrophosphate (PPi) suppresses HA
crystal formation and propagation and acts as a potent
calcification inhibitor in biologic fluids.(5) Three molecules have
been identified as central regulators of extracellular PPi levels,
namely, tissue-nonspecific alkaline phosphatase (TNAP), which
is the primary enzyme that hydrolyzes PPi in the ECM
(6–10);
nucleotide pyrophosphatase phosphodiesterase 1 (NPP1), which
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generates PPi ectoplasmically from nucleoside tripho-
sphates(11,12); and the multiple-pass transmembrane protein
ANK, which mediates intracellular to extracellular channeling
of PPi.
(13,14)
TNAP is expressed at high levels in skeletal tissues, where it is
found on the cell surfaces of odontoblasts, chondrocytes, and
osteoblasts, including the membranes of their shed MVs.(15)
Accumulation of PPi in skeletal tissue caused by loss of TNAP’s
pyrophosphatase function leads to hypophosphatasia (HPP),
an inborn error of metabolism characterized by rickets and
osteomalacia.(16,17) Mice deficient in TNAP function (Akp2/)
phenocopy infantile HPP; that is, they are born with normally
calcified skeletons but by postnatal days 6 to 10, hypominer-
alization of the skeleton becomes apparent and worsens with
age until their early demise by postnatal day 20.(18,19) The failure
of bones to calcify after birth appears to result from a block in the
propagation of HA in the ECM beyond the confines of the MV
membrane(20,21) as a consequence of accumulated levels of PPi
in the ECM resulting from the lack of TNAP’s pyrophosphatase
function(9,10,17,22) together with the concomitant pyropho-
sphate-induced increase in osteoblast production of osteopon-
tin, another potent inhibitor of calcification.(23,24) However,
chondrocyte- and osteoblast-derived MVs in both HPP patients
and Akp2/ mice retain the ability to initiate intravesicular
mineral formation and contain HA crystals,(20,21) demonstrating
that TNAP is not essential for the initiation of MV-mediated
ECM mineralization and suggesting that other phosphatases
or another mechanism might be responsible for this first
step.
The phosphatase PHOSPHO1, first identified in the chick(25) as
a member of the haloacid dehalogenase (HAD) superfamily
of Mg2þ-dependent hydrolases,(26) is expressed at levels 100-fold
higher in mineralizing than in nonmineralizing tissues.(27)
PHOSPHO1 shows high phosphohydrolase activity toward
phosphoethanolamine (PEA) and phosphocholine (PCho),(28) is
present and active inside chondrocyte- and osteoblast-derived
MVs,(29) and the use of small-molecule compounds to inhibit
PHOSPHO1 activity in Akp2/ MVs led to a significant decrease
in MV-mediated calcification in vitro.(30) We surmised that
PHOSPHO1 is involved in the first step of MV-mediated initiation
of mineralization during endochondral ossification. In this
article, we demonstrate conclusively the functional role of
PHOSPHO1 during endochondral ossification and provide a
unified, comprehensive model of the mechanisms of initiation of
skeletal mineralization.
Methods
Mice
Phospho1-R74X null mutant (Phospho1/) mice were generated
by N-ethyl-N-nitrosourea mutagenesis (ENU) in the C3HeB/FeJ
(Stock No. 000658, Jackson Laboratories, Bar Harbor, ME, USA)
background and bred to C57Bl/6 mice to segregate other
possible undesired mutations. The generation of Akp2/ mice
has been reported previously.(18) The Akp2/ mice used in
this study were hybrids of C57Bl/6X129J mouse strains. The
generation and characterization of the ApoE-Tnap transgenic
mouse line has been described previously.(10) The homozygote
mice exhibit up to 50-fold higher plasma levels of TNAP,
produced primarily by the liver. The respective Institutional
Animal Care and Use Committees (IACUCs) approved all animal
studies.
Tissue analysis
Whole-mount skeletal preparations were processed as
before.(9,22) The lumbar spines, tibias, and femurs of 10-day-
old mice and whole bodies of E16.5 embryos were fixed in PBS
containing 4% (vol/vol) paraformaldehyde or a fixative contain-
ing 4% paraformaldehyde and 1% glutaraldehyde solution in
0.1M sodium cacodylate buffer, pH. 7.2. Optimal cutting tem-
perature compound (OCT) or paraffin sections were stained with
the hematoxylin and eosin, alizarin red/alcian blue, von Kossa/
van Gieson, and von Kossa/toluidine blue stains using standard
procedures.(10,32,33) Von Kossa/van Gieson–stained slides were
used for quantification of osteoid volume using the Bioquant
Osteo Software (Bioquant Osteoanalysis Co., Nashville, TN, USA).
Whole-body radiographic images were taken using an MX20
Specimen Radiograph System (Faxitron X-ray Corporation,
Chicago, IL, USA) at different developmental ages (days 1, 3,
and 10, 1 month, and 1 year). Tibia and femur lengths were
measured using calipers. Micro–computed tomographic (mCT)
analysis was carried out as described before.(21,23,31) Protein
extracts (100mg) from long bones of the Phospho1/ and WT
mice were obtained as described previously(31) and used for
Western blotting. PHOSPHO1 protein was detected with a
recombinant human Fab antibody fragment selected against a
human recombinant PHOSPHO1 (AbD05643.1) at a concentra-
tion of 1mg/mL (AbD Serotec, MorphosysAG, Martinsried/
Planegg, Germany). Recombinant human PHOSPHO1 protein(30)
(20 ng) was used as a positive control.
Cell-based assays
Primary calvarial osteoblasts were isolated from 1- to 3-day-old
pups, and primary chondrocytes were isolated from the knee
joint growth plates of 5-day-old pups by collagenase digestion,
as described previously.(9,22,23) RNAwas extracted using RNAeasy
Pus Kit (Qiagen, Valencia, CA, USA). Specific RNA transcripts
(mRNA) were quantified by real-time PCR using dual-labeled
hydrolysis probes (FAM-TAMRA) (see Supplemental Text).
Alizarin red S binding assay was performed using a standard
method.(34) MVs were isolated from primary osteoblasts and
chondrocytes by collagenase digestion and assayed for their
calcification ability, as described previously.(35)
Biochemical assays
Blood was collected by cardiac puncture or by eye bleed into
lithium heparin tubes. TNAP and NPP1 activities were measured
using colorimetric assays, as described previously.(35) PPi con-
centrations were measured as described previously.(34)
Statistical analysis
All measurements were performed at least in triplicate. Results
are expressed as mean SEM and mean SD for mCT analysis of
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trabecular and cortical bone and ashing analysis. The data were
analyzed using Student’s t test. For mCT analysis, a Mann-
Whitney test was conducted instead of a t test. For analysis of the
mineral content, a rank-sum test was used. P values less than .05
are considered significant.
Results
Phospho1/mice exhibit poor weight gain, growth plate
and skeletal abnormalities, and thoracic scoliosis
Phospho1-R74X null mutant (Phospho1/) mice were generated
by ENUmutagenesis. The absence of PHOSPHO1 protein in these
mice was confirmed by Western blot analysis (Fig. 1A). The
protein band of approximately 29 kDa corresponding to the
native PHOSPHO1 protein can be seen in protein extracts of long
bones of WT mice but not in the Phospho1/ samples.
Both male and female Phospho1/mice are smaller than age-
matched heterozygous and WT controls (Fig. 1B) and exhibit
growth retardation (Fig. 1C), where bones from 1-month-old
male mice are shorter (ie, tibia: 16.3 0.2mm and 14.1 0.6mm,
p¼ .0002; and femur: 12.4 0.5mm and 11.4 0.6mm,
p¼ .0045, for WT and Phospho1/ mice, respectively). The
difference in body weights is more prominent after 2 months of
age and remains persistent thereafter. Studies using metabolic
cages revealed that Phospho1/ mice eat (Fig. 1D) and drink
(Fig. 1E) considerably less thanWT littermates. Visual observation
of the food pellets revealed less evidence of chewing in the
Phospho1/ mice. Thoracic scoliosis was present in approxi-
mately 30% to 40% of the Phospho1/ mice on day 10, but at
1 month of age, scoliosis was clearly evident in 100% of
Phospho1/ mice, and this spine deformity worsened progres-
sively and became very prominent at 1 year of age (Fig. 1F).
Greenstick fractures were present from postnatal day 1 in the
vertebrae and hind and forelimbs of Phospho1/mice (Fig. 1G).
Whole-mount skeletal preparations of 10-day-old mice showed
callus formation at the sites of fractures in the ribs of Phospho1/
mice and curved long bones in the hind and forelimbs (Fig. 2A).
Histologic analysis of the cryosections of tibia stained
with alizarin red/alcian blue staining (Fig. 2B) showed reduced
mineralization of the trabecular bone. About 10% to 15% of
10-day-old Phospho1/ mice showed complete absence of
secondary ossification centers. Von Kossa/van Gieson staining
(Fig. 2C) revealed characteristics of osteomalacia in Phospho1/
mice: widespread excessive osteoid (OV/BV¼ 3.96% in Phos-
pho1/mice versus 0.06% in WT mice, p¼ .0001) and increased
width of osteoid at the surfaces of both trabecular and cortical
bone. Histochemical staining showedmarkedly reduced levels of
TNAP activity in the hypertrophic chondrocytes, metaphyseal
trabecular bone, and secondary ossification centers in the femur
of Phospho1/mice (data not shown). mCT analysis of 1-month-
old Phospho1/ and WT mice showed no significant difference
in tibia and femur trabecular BV/TV ratio (Supplemental Table
S1), but the cortical bone mineral density (BMD) was significantly
reduced in both femur (p¼ .003) and tibia (p¼ .038; Fig. 3A, B).
Ashing analysis of the humeri confirmed the decreased BMD of
the Phospho1/mice, where the percent ash content of the WT
mice was significantly higher than the percent ash content of
the Phospho1/ mice (55% 4% versus 50% 7%, p¼ 0.038).
We detected increased cortical porosity in the femur and
decreased cortical thickness in the tibia of Phospho1/ mice
(Supplemental Table S1). The increased BMD measured in the
medular cavity of the tibia is likely a result of the increased
trabecular number and decreased spacing noted in the
Phospho1/ mice (Fig. 3C and Supplemental Table S1). mCT
images of the spine, taken at 1 month of age, showed scoliosis in
Phospho1/ mice (Fig. 3D). Both dextro- and levoscoliosis was
observed in these mice, but high-resolution mCT images did not
reveal any morphologic vertebral abnormalities (Fig. 3E).
Biochemical changes in Phospho1/ mice
Serum glucose, blood urea nitrogen, creatinine, albumin,
globulin, total protein, total bilirubin, sodium, potassium, and
calcium were normal in 10-day-old as well as 1-year-old
Phospho1/ mice (Supplemental Table S2). A slight hyperpho-
sphatemia was observed transiently in 10-day-old Phospho1/
mice. A comprehensive pathologic exam of soft tissues did not
reveal any abnormalities in the kidneys, liver, spleen, lungs, heart,
thymus, or gastrointestinal tract of 20-day-old Phospho1/
mice. We measured expression of Runx2, Col2a1, Col10a1,
aggrecan, and MMP13 in 1-, 7-, and 14-day-old growth plate
chondrocyte cultures from WT and Phospho1/mice. We found
a statistically significant decrease in Col2a1, aggrecan, andMPP13
expression in Phospho1/ chondrocyte cultures and a statis-
tically significant decrease in Col10a1 expression in 14-day
cultures (Supplemental Fig. S1).
In agreement with the observation of the reduced levels of
TNAP activity in the growth plates, metaphyseal trabecular bone
and secondary ossification centers in Phospho1/mice, we also
found reduced levels of TNAP activity in the plasma of 1-year-old
Phospho1/mice (Fig. 4A; p¼ .012). We also observed increased
plasma activity of NPP1 (p¼ .004), and as a consequence of the
reduced TNAP and enhanced NPP1 activity, Phospho1/ mice
had higher than normal levels of plasma PPi (1.24 0.2mmol/L)
compared with WT mice (0.7 0.07mmol/L, p¼ 0.009; Fig. 4A).
These biochemical changes were confirmed at the mRNA level in
cultures of both primary chondrocytes (Fig. 4B) and osteoblasts.
WT chondrocytes were grown in culture for 14 days in the
presence of differentiation medium containing ascorbic acid,
and Phospho1 mRNA expression was assessed on each day. The
highest Phospho1 gene expression was observed on day 1 of
culture, and therefore, 1-day-old chondrocytes were used for
TNAP (Akp2) and NPP1 (Enpp1) expression studies. In agreement
with the biochemical measurements, quantitative PCR (qPCR)
studies of mRNA isolated from 1-day-old chondrocytes cultures
(Fig. 4B) revealed a 2-fold decrease in Akp2 mRNA (p¼ .017), a
2.5-fold increase in Enpp1 mRNA (p¼ 0.032), and a 1.6-fold
increase in AnkmRNA (p¼ 0.038) in Phospho1/ cells compared
with WT cells. The mineralizing ability of Phospho1/ primary
chondrocytes was reduced in comparison with WT chondrocytes
(0.59 0.04 versus 0.36 0.03mmol of alizarin red–bound/cetyl
pyridinium phosphate in WT and Phospho1/ mice, respec-
tively, p¼ 0.009; Fig. 4C). These observations were extended to
the level of the chondrocyte-derived MVs, where again we
observed a decrease in TNAP activity (Fig. 4D; p¼ .016) and an
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Fig. 1. Phenotypic abnormalities in Phospho1-R74X (Phospho1/) mice. (A) Western blot showing the absence of PHOSPHO1 protein in Phospho1/
mice. (B) Radiographic images of 10-day-old male mice showing the smaller size of Phospho1/ compared with WT mice. (C) Body weights of WT,
Phospho1þ/, and Phospho1/ female mice and Phospho1/male mice from birth onwards. (D) Food (N¼ 4, p¼ .0001) and (E) water (N¼ 4, p¼ .0024)
consumption by WT and Phospho1/ mice measured per day for 3 consecutive days. (F) Radiographic images of WT and Phospho1/ mice at 3 and
10 days of life, 1month, and 1 year of age. Phospho1/mice showed clavicle (arrow) and rib deformities and scoliosis (arrow), clearly evident at 1month of
age in all Phospho1/ mice, which becomes progressively worse with age. (G) Bowed long bones of both the hind and forelimbs, and evidence of
spontaneous greenstick fractures is apparent.
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increase in NPP1 activity (Fig. 4D; p¼ .05) in MVs isolated from
Phospho1/ mice compared with WT mice. The Phospho1/
MVs showed reduced calcification ability (14.76mmol
calcium/mg of protein) compared with WT MVs (22.44mmol
calcium/mg of protein; Fig. 4E; p¼ .002).
The Phospho1/ phenotype is not rescued by
overexpression of TNAP
The increased levels of plasma PPi and the reduced activity of
TNAP observed in Phospho1/ mice are reminiscent of the
changes observed in HPP, where the elevated PPi levels are
responsible for the ensuing rickets and osteomalacia character-
istic of this disease.(9,16,17,19) The HPP phenotype can be
completely rescued by cross-breeding Tnap null (Akp2/) mice
with transgenic mice overexpressing TNAP under control of
the ApoE promoter.(10) In order to assess whether the phenotypic
abnormalities observed in the Phospho1/ mice were attribu-
table to altered PPi metabolism, we cross-bred Phospho1
/ to
ApoE-Tnap transgenic mice. [Phospho1/; ApoE-Tnap] mice
did not show any significant improvement in their skeletal
phenotype at 10 days of age, as assessed by radiography and
histology of the femur (Fig. 5A, B), despite a significant reduction
in the circulating levels of PPi (Phospho1
/ mice¼ 1.02
0.04mmol/L and [Phospho1/; ApoE-Tnap] mice¼ 0.89
0.05mmol/L, p¼ .0348) and a significant increase (4 fold) in
the plasma levels of TNAP (Phospho1/ mice¼ 197 25 U/L
and [Phospho1/; ApoE-Tnap] mice¼ 933 130 U/L, p< .0001).
NPP1 levels did not show any significant change (Phospho1/
mice¼ 344 19 U/L and [Phospho1/; ApoE-Tnap] mice¼
307 19 U/L, p¼ .26). Analysis of 3.5- and 7-month-old
[Phospho1/; ApoE-Tnap] mice showed no correction of the
skeletal phenotype despite the persistently high levels of plasma
TNAP activity ([Phospho1/; ApoE-Tnap] mice¼ 1940 242,
p¼ .0003 U/L; Phospho1/ mice¼ 61 20 U/L, and WT
mice¼ 179 18 U/L) and normal levels of PPi ([Phospho1/;
ApoE-Tnap] mice¼ 3.2 0.4mmol/L, p¼ .0018, N¼ 8; Phos-
pho1/ mice¼ 4.4 0.6mmol/L,N¼ 5, and WT mice¼ 2.9
0.1mmol/L,N¼ 12). [Phospho1/; ApoE-Tnap] mice manifested
the same decrease in food and water consumption observed in
the Phospho1/ mice.
Nonredundant role of PHOSPHO1 in skeletal
mineralization
The fact that overexpression of TNAP does not prevent the
development of skeletal abnormalities in the Phospho1/mice,
despite correction of plasma PPi and greatly elevated TNAP
levels, suggests that PHOSPHO1 functions through a pathway
that is distinct from that of TNAP. We predicted, therefore, that
Fig. 2. Whole mounts and histologic analyses of tibias and femurs of 10-day-old WT and Phospho1/ mice. (A) Alizarin red/alcian blue staining of the
whole skeleton ofWT and Phospho1/mice. Phospho1/mice show callus formation at the sites of fractures in the ribs (arrows) and curved long bones in
both hind and forelimbs (arrows). Tibial sections at the knee joint show growth plates of the WT and Phospho1/mice stained with (B) alizarin red/alcian
blue and reveal reduced mineralization in Phospho1/mice. (C) Von Kossa/van Gieson staining of the femoral section at the knee joint reveals trabecular
bone surrounded by widespread, extended osteoid in Phospho1/ mice.
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the simultaneous ablation of PHOSPHO1 and TNAP function
would severely compound the mineralization phenotype
characteristic of each individual knockout model. Deleting a
single allele of Akp2 (TNAP) in the Phospho1 null background
aggravated the skeletal phenotype of Phospho1/ mice
(Fig. 6A). [Phospho1/; Akp2þ/] pups were born but at a
greatly reduced rate (5.8% compared with the expected 12.5%;
Supplemental Table S3). Multiple fractures were seen from
postnatal day 1, and prominent scoliosis was observed already
on postnatal day 10 in [Phospho1/; Akp2þ/] mice compared
with 1 month of age in Phospho1/ mice. mCT analysis of the
bones in [Phospho1/; Akp2þ/] mice also showed highly
curved tibias at the site of the fractures, and secondary
ossification centers were smaller and less developed than in
the Phospho1/ mice (Fig. 6B). Histologic analysis of the von
Kossa/toluidine blue–stained sections of the tibias (Fig. 6C) also
showed reduced secondary ossification centers and deformed
cortical bone compared with Phospho1/ and WT mice. Similar
findings also were observed in the digits and third metatarsal.
Transmission electronmicroscopic images of the thirdmetatarsal
bones showed decreased bone mineralization in the ECM in the
Phospho1/mice and greatly reduced bone ECMmineralization
(osteoidosis) in the [Phospho1/; Akp2þ/] mice.
Of 272 pups born to Phospho1þ/ Akp2þ/ and [Phospho1/;
Akp2þ/] [Phospho1/; Akp2þ/] matings (Supplemental
Table S3), only one double-knockout [Phospho1/; Akp2/]
Fig. 3. mCT analysis of 1-month-old WT and Phospho1/mice. (A, B) Decreased cortical BMD in femur (p¼ .003) and tibia (p¼ .038) of 1-month-old male
Phospho1/ mice (WT, N¼ 7; Phospho1/ mice, N¼ 9). (C) mCT images showing increased trabeculi and decreased trabecular spaces in tibia of the
Phospho1/ bones. (D) mCT images of the spine show scoliosis in Phospho1/ mice. (E) High-resolution mCT images of the spine showing no obvious
morphologic abnormalities in the individual Phospho1/ vertebrae.
ABLATION OF SKELETAL MINERALIZATION IN AKP2/PHOSPHO1 DOUBLE-KNOCKOUT MICE Journal of Bone and Mineral Research 291
Fig. 4. Biochemical and gene expression changes in Phospho1/ mice. (A) One-year-old Phospho1/ mice show reduced plasma TNAP activity [N¼ 6
(WT); N¼ 8 (Phospho1þ/); N¼ 8 (Phospho1/), p¼ .012], increased plasma NPP1 activity [N¼ 8 (WT); N¼ 13 (Phospho1þ/); N¼ 16 (Phospho1/),
p¼ .004], and high plasma PPi levels [N¼ 13 (WT); N¼ 10 (Phospho1þ/); N¼ 11 (Phospho1/), p¼ .009] comparedwith heterozygous andWT littermates.
(B) Decreased Akp2 and increased Enpp1 mRNA expression in day 1 chondrocytes assessed by qPCR. Data are represented as mean SEM, N ¼3,
experiments done in triplicates. (C) Decreased mineralization (alizarin red staining) in Phospho1/ chondrocytes grown in the presence of mineralization
medium containing ascorbic acid and b-glycerophosphate for 14 days and alizarin red measurements. (D) MVs from Phospho1/mice showed reduced
TNAP activity (p¼ .016), increased NPP1 activity (p¼ .05), and (E) reduced calcification ability (p¼ .002) compared with WT MVs. Data are represented as
mean SEM, N ¼3 experiments done in triplicate.
Fig. 5. The Phospho1/ phenotype is not rescued by overexpression of TNAP; X-ray images of the skeleton of a 10-day-old [Phospho1/; ApoE-Tnap]
mice. No improvement in the skeletal phenotype of 10-day-old Phospho1/mice was observed by overexpressing TNAP as assessed by (A) radiography
and (B) osteoid measurement in the femur after von Kossa/van Gieson staining.
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pup was born, and that was a stillbirth. mCT analysis of the P0
stillborn [Phospho1/; Akp2/] specimen revealed complete
lack of mineralization in the appendicular skeleton (Supple-
mental Fig. S2). The axial skeleton also was highly deformed and
only partially mineralized, as were some craniofacial bones. Since
ablating both PHOSPHO1 and TNAP function appeared perinatal
lethal, we examined [Phospho1/; Akp2/] embryos. The
expected percentage and numbers of E16.5 [Phospho1/;
Akp2/] double-knockout embryos were obtained and
studied (N¼ 6). Figure 7A shows the mCT analysis of an E16.5
[Phospho1/; Akp2/] embryo showing complete lack of
skeletal mineralization. Alizarin red/Alcian blue staining of the
transversal sections of the embryos shows reduced calcification
of the vertebral bones and femur of the E16.5 Phospho1/
embryo compared to the WT E16.5 control and Akp2/
embryos. The [Phospho1/; Akp2/] embryos showed a
complete absence of skeletal mineralization (bone and cartilage;
Fig. 7B, C). Von Kossa and van Gieson staining of the vertebral
bones also showed a complete lack of mineralization in the
[Phospho1/; Akp2/] specimens (Fig. 7D).
Discussion
We have studied the role of PHOSPHO1 during endochondral
ossification by examining the phenotypic alterations resulting
from ablation of PHOSPHO1 function alone or in combination
with TNAP deficiency. Lack of PHOSPHO1 caused a decrease in
growth rate, endochondral growth plate, and skeletal abnorm-
alities that included decrease or loss of secondary ossification
centers, decreased bone mineral density, spontaneous fractures,
Fig. 6. Worsening of the skeletal abnormalities on ablating Akp2 alleles in Phospho1/mice. (A) Radiographic images of WT and [Phospho1/; Akp2þ/]
mice on postnatal days 10 and 25. All the skeletal abnormalities of Phospho1/mice were aggravated in [Phospho1/; Akp2þ/] mice. Multiple fractures
and highly deformed long bones were observed from day 1, and scoliosis was evident as early as day 10 in all the [Phospho1/; Akp2þ/] mice. (B) mCT
images of WT, Phospho1/, and [Phospho1/; Akp2þ/] mice. Highly curved tibias and smaller secondary ossification centers in [Phospho1/; Akp2þ/]
mice. (C) Sections (1mm) stained with von Kossa/toluidine blue show deformed cortical bone and reduced secondary ossification centers in [Phospho1/;
Akp2þ/] and Phospho1/ mice.
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osteomalacia, and scoliosis. Cultured growth plate chondrocytes
showed decreased expression of differentiation markers,
including Col2a1, aggrecan, MMP13, and Col10a1, indicative of
a cellular growth plate phenotype, and chondrocytes and
osteoblasts from Phospho1/ mice, as well as their derived
MVs, displayed a reduced ability to calcify, consistent with
the reduced mineralization of their skeleton, clearly demonstrat-
ing that PHOSPHO1 is required for normal endochondral
ossification.
Metabolic studies indicated that the reduced growth rate of
Phospho1/ mice was attributable to reduced food and water
consumption. Visual observation of the food pellets revealed less
evidence of chewing in the Phospho1/ mice. We surmise that
this might be caused by softer jaws and/or teeth and reduced
mobility resulting from the hypomineralization phenotype in the
Phospho1/ mice. We are currently examining tooth develop-
ment and tooth mineralization to better understand this aspect
of the phenotype in Phospho1/ mice. Functional adaptation
Fig. 7. Lack of skeletal mineralization in [Phospho1/; Akp2/] double-knockout mice. (A) mCT image of an [Phospho1/; Akp2/] E16.5 embryo shows
complete absence of skeletal mineralization compared withWT, Phospho1/, and Akp2/ embryos. (B) Alizarin red/alcian blue staining of the transversal
section from the lower body of E16.5 WT, Phospho1/, Akp2/, and [Phospho1/; Akp2/] double-knockout embryos. Higher magnification (20) of a
vertebral bone showing completely absent mineralization in the [Phospho1/; Akp2/] specimen and reduced mineralization in the Phospho1/
embryo, as detected by (C) alizarin red/alcian blue staining and (D) von Kossa/van Gieson staining.
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and changes in mechanical loading(36,37) can explain the
different architectural changes noted in the Phospho1/ mice
in the tibia and femur. Both levo- and dextroscoliosis can be seen
in Phospho1/ mice, but detailed examination of the vertebrae
by mCT ruled out the presence of obvious morphologic vertebral
abnormalities (hemivertebrae or fused vertebrae), indicating that
the scoliosis, as well as the bowing of long bones, is likely caused
by muscular forces acting on the malleable hypomineralized
matrix of the Phospho1/ mice.(38,39)
Cultures of Phospho1/ growth plate chondrocytes revealed
decreased expression of Col2a1, aggrecan, MMP13, and Col10a1,
indicating a cell differentiation phenotype compatible with the
subtle morphologic changes observed in the histologic sections
of the growth plates. Of particular interest was the fact that the
Phospho1/ mice showed enhanced production (high NPP1
activity), enhanced transport (high ANK expression), and
decreased degradation (reduced TNAP activity) of PPi, a situation
that was highly reminiscent of that encountered in Akp2/mice
(deficient in TNAP), where elevated levels of PPi explained the
rickets/osteomalacia characteristic of HPP in this knockout
model.(19) However, correcting PPi levels in Akp2
/ mice, either
via transgenic overexpression of TNAP into the Akp2 null
background, that is, in [Akp2/; ApoE-Tnap] mice,(10) or via the
use of enzyme-replacement therapy with a bone-targeted form
of TNAP,(32) completely prevented the development of skeletal
and dental abnormalities characteristic of this model of infantile
HPP. This was not the case, however, when PPi levels were
reduced and plasma TNAP levels were highly increased in
Phospho1/ mice by cross-breeding them with the same ApoE-
Tnap transgenic mice. These data indicate that while PHOSPHO1
function can influence expression of the molecules involved
in PPi metabolism, that is, NPP1, ANK, and TNAP, the phenotypic
abnormalities in Phospho1/ mice cannot be explained simply
by the resulting modulations in PPi concentrations. Furthermore,
the fact that the double ablation of PHOSPHO1 and TNAP
function leads to an essentially complete absence of miner-
alization provides compelling experimental evidence supporting
the assertion that PHOSPHO1 and TNAP have independent,
nonredundant roles during endonchondral ossification.
PHOSPHO1 is a soluble cytosolic enzyme that has specificity
for phosphoethanolamine (PEA) and phosphocholine (PCho).(28)
Both PEA and PCho are the two most abundant phosphomo-
noesters in cartilage,(40) and the PEA and PCho composition of
the MV membrane decreases during mineralization, in conjunc-
tion with phospholipase C activity.(41) The low PCho accumula-
tion in mineralizing compared with nonmineralizing cells is
compatible with the upregulation of PHOSPHO1 activity in
mineralizing cells, whose function reduces the levels of PEA and
PCho in chondrocytes and osteoblasts.(42) The very low Km values
for both PEA and PCho (mM range) indicate that under
physiologic conditions, PHOSPHO1 rapidly hydrolyzes both
molecules.(28) Thus, through the enzymatic action of PHOSPHO1,
as part of the mineralization process, Pi appears to be scavenged
from PEA and PCho in order to generate the Pi concentration
needed to establish a Pi/PPi ratio permissive for the initial
formation of HA crystal inside the MVs. It is clear from our data
that modulating PHOSPHO1 function influences the expression
of the Enpp1, Ank, and Akp2 genes, given the expression changes
observed in the Phospho1/ cells. But why did the functional
ablation of PHOSPHO1 not abolish initiation of HA deposition
inside MVs, whereas there was a tremendous decrease in
mineralization of the skeleton after the double ablation of
PHOSPHO1 and TNAP? To answer this question, one must first
review the literature regarding the expression of TNAP and NPP1
in the appendicular and axial skeletons and also review the
kinetic properties of TNAP and NPP1 toward physiologic
substrates ATP, ADP, and PPi at the level of MVs.
It has been proposed that the role of TNAP in the bone matrix
is to generate the Pi needed for HA crystallization.
(7,43,44)
However, TNAP also has been shown to hydrolyze the
mineralization inhibitor PPi to facilitate mineral precipitation
and growth.(6,7) Previous studies from this laboratory and
collaborators have shown conclusively that a major function
of TNAP in bone tissue consists of hydrolyzing PPi to maintain a
proper concentration of this mineralization inhibitor to ensure
normal bone mineralization,(8,9,21,22) and we have even shown
that the coexpression of TNAP and fibrillar collagens is
‘‘necessary and sufficient’’ to cause ECM calcification.(10) The
major conclusion of that article was that the pervasive presence
of the potent calcification inhibitor PPi in all body fluids prevents
unwanted calcification in tissues other than bones and teeth.
However, transgenic overexpression of TNAP can lead to a
decrease in local PPi concentrations that enable the spontaneous
crystallization of ionic calcium and Pi to form bonemineral within
a fibrillar/collagenous scaffold. In turn, lack of TNAP in Akp2/
mice leads to accumulation of extracellular PPi that causes the
rickets and dental abnormalities characteristic of infantile
HPP.(19,32) Cross-breeding of Akp2/ to Enpp1/ mice leads
to normalization of the extracellular PPi levels and correction of
the skeletal defects in [Akp2/; Enpp1/] double-knockout
mice.(9) However, this genetic correction is only partial, with
major improvements observed in the axial skeleton but only
partial changes observed in the appendicular skeleton.(31) This is
attributable to the different levels of expression of NPP1 in these
skeletal environments; that is, NPP1 is highly expressed in the
calvaria, but expression is much lower in the femurs/tibias of
mice.(31) Thus ablation of the PPi-generating activity of NPP1 in
the axial skeleton (calvarium and spine) of Akp2/mice led to a
significant reduction in PPi production in skeletal sites that was
sufficient to normalize PPi concentrations and prevent hypomi-
neralization. However, ablating the lower levels of NPP1 in
the appendicular skeleton was not sufficient to adequately
reverse PPi levels back to normal in those sites, and inadequate
mineralization persisted.(31) Recent data from our laboratory
indicate that besides the PPi-generating activity of NPP1 in
chondrocytes and osteoblasts, at the level of MVs, NPP1 can act
as an efficient phosphatase, producing Pi from ATP, ADP, and PPi,
but that this activity is evident only in the absence of TNAP,
which is a much more efficient phosphatase for all these three
physiologic substrates.(35) These new data help to explain why
Akp2/ mice, which are null for TNAP activity, display an HPP
phenotype that is less severe than the most severe cases of
human HPP reported, such as lethal and perinatal HPP.(16,17) In
the absence of TNAP, NPP1 can act as a backup pyrophosphatase
in the extravesicular space to temporarily restrict the concentra-
tions of extracellular PPi to allow Akp2
/ mice to develop
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normal mineralization for the first 6 days of life. After that, the
hypomineralization abnormalities become apparent. This partial
compensatory pyrophosphatase activity of NPP1 also explains
why in the single stillborn [Phospho1/; Akp2/] double-
knockout pup reported in this article, there was some partial
mineralization of the axial skeleton.
Several articles have involved the action of ATPases in the
initiation of endochondral ossification.(45–47) The article by
Ciancaglini and collaborators clearly has documented that the
major ATPase of MVs is TNAP but that NPP1 can act as an ATPase
in the absence of TNAP.(35) In contrast, PHOSPHO1 is a very
inefficient phosphatase when confronted with ATP, ADP,
or PPi.
(35) These data are very relevant to understanding the
roles of organic and inorganic phosphates in endochondral
ossification and in explaining the complete ablation of skeletal
mineralization in [Phospho1/; Akp2/] double-knockout
embryos. Calcification, both intravesicular and extravesicular,
is abolished in [Phospho1/; Akp2/] embryos despite the
availability of systemic Pi in these mice. This argues that organic
phosphates, such as ATP or ADP, might act as the major source
of Pi that is required for the initiation of calcification.
Chondrocytes, osteoblasts, and their derived MVs express and
use phosphate transporters on their membrane for uptake
of Pi.
(48,49) We must conclude that the mineralizing cells consider
it efficient to invest the energy required to generate and export
ATP to be used for the local generation of Pi in the immediate
environment of MVs and for subsequent incorporation into MVs
via Pi transporters. Thus, in the absence of both PHOSPHO1 and
TNAP function, there is complete lack of skeletal mineralization
because there is no Pi generation from substrates attributable to
the absence of TNAP’s ATPase activity, and the levels of ATPase
provided by NPP1 in the embryonic skeleton are clearly
insufficient to allow calcification to proceed. However, some
calcification still was observed in the axial skeleton of the single
stillborn [Phospho1/; Akp2/] double-knockout pup likely
attributable to Pi generation via the ATPase action of NPP1 and
also by the concomitant restriction of extracellular PPi con-
centrations by the pyrophosphatase activity of NPP1. Thus this
provides an explanation why complete ablation of PHOSPHO1
function leads only to a decrease in the calcification ability of
MVs but not to a complete lack of calcification, as we showed
previously using small-molecule inhibitors of PHOSPHO1
activity(30) and in this article by the gene-knockout approach.
Deletion of PHOSPHO1 would suppress intravesicular generation
of Pi but would leave extravesicular Pi generation via TNAP’s
ATPase activity and influx via Pi transporters unaffected.
Integrating these data, it is now possible to propose an
inclusive model for the initiation of skeletal mineralization that
unifies a number of concepts and functions that have been
considered contradictory in the past. Our unified model starts
with the MVs as the site of initiation of mineralization
(Supplemental Fig. S3). HA crystals appear inside the MVs
favored by Pi accumulation resulting from a dual mechanism,
that is, PHOSPHO1-mediated intravesicular production and
transporter-mediated influx of Pi produced extravesicularly
primarily by TNAP’s ATPase activity or, secondarily, in the
absence of TNAP by NPP1’s ATPase activity. Organophosphate
compounds, and perhaps also PPi, are the source of Pi for this
initial step of calcification. Then extravesicular calcification is
supported mainly by TNAP’s pyrophosphatase activity and,
secondarily, by NPP1’s pyrophosphatase activity (in the absence
of TNAP) and is driven by the availability of Pi and the presence of
a collagenous fibrilar scaffold and guided by other ECM mineral-
binding proteins. This proposed model, compatible with all
available experimental data, takes into account the roles of both
organic and inorganic phosphates in skeletal calcification and
unifies the roles of MV- and collagen-mediated calcification as
two separate but linked steps during endochondral ossification.
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